New blood test could Fine-Tune treatment for iron overload disease
NCT ID NCT00007150
Summary
This study is testing a simple blood test to better guide treatment for people with hereditary hemochromatosis, a condition where the body absorbs too much iron, which can damage organs. The main treatment is regular blood draws (phlebotomy) to lower iron levels. Researchers want to see if monitoring red blood cell size (MCV) is as good as or better than the standard test at determining when to draw blood. They will also check if keeping iron very low helps heal liver damage and arthritis, and explore if the drawn blood can be safely used for other patients needing transfusions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOCHROMATOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.